Journal of Addiction Research & Therapy
黑料网
Like us on:
organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 4859
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- SafetyLit
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Journal of Addiction Research & Therapy : Citations & Metrics Report
Articles published in Journal of Addiction Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Addiction Research & Therapy has got h-index 34, which means every article in Journal of Addiction Research & Therapy has got 34 average citations.
Following are the list of articles that have cited the articles published in Journal of Addiction Research & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
Total published articles |
88 | 88 | 61 | 59 | 24 | 28 | 24 | 59 | 48 |
Research, Review articles and Editorials |
20 | 68 | 49 | 7 | 8 | 18 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
68 | 0 | 1 | 15 | 3 | 1 | 0 | 0 | 0 |
Conference proceedings |
0 | 11 | 5 | 0 | 0 | 0 | 85 | 56 | 105 |
Citations received as per Google Scholar, other indexing platforms and portals |
90 | 168 | 573 | 612 | 590 | 545 | 567 | 473 | 440 |
| Journal total citations count | 4859 |
| Journal impact factor | 9.79 |
| Journal 5 years impact factor | 14.65 |
| Journal cite score | 13.41 |
| Journal h-index | 34 |
| Journal h-index since 2019 | 26 |
 |
O'Neill N (2014) Mephedrone and multiplicity: User accounts of effects and harms. Contemporary Drug Problems 41: 417-443. |
| | | |
|
|
| | | |
|
Ben Mosbah H. " I was like a rose, now I look like a thorn" An exploratory study of women injecting drug users (WIDU) in Tunisia. |
| | | |
|
Beijer U, Scheffel Birath C, DeMartinis V, af Klinteberg B (2015) Facets of male violence against women with substance abuse problems: women with a residence and homeless women. Journal of interpersonal violence: 0886260515618211. |
| | | |
|
Dufort M, Stenbacka M, Gumpert CH (2015) Physical domestic violence exposure is highly associated with suicidal attempts in both women and men. Results from the national public health survey in Sweden. The European Journal of Public Health 25: 413-418. |
| | | |
|
Blum K, Febo M, D Badgaiyan R, R Braverman E, Dushaj K, et al. (2016) Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity. Current Pharmaceutical Design 22: 5837-5854. |
| | | |
|
Blum K, Febo M, Fried L, Li M, Dushaj K, et al. (2017) Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS). Substance Use & Misuse 52: 535-547. |
| | | |
|
Blum K, Gold M, Clark HW, Dushaj K, Badgaiyan RD (2016) Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?. Substance use & misuse 51: 1674-1679. |
| | | |
|
Blum K, Oscar-Berman M, Blum SH, Madigan MA, Waite RL, et al. (2014) Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?. Journal of alcoholism and drug dependence: 2. |
| | | |
|
Elian AA, Hackett J (2015) Urine analysis of buprenorphine/norbuprenorphine/naloxone in drugs and driving cases. J Appl Bioanal 1: 80-88. |
| | | |
|
Blum K, Han D, Giordano J, Lohmann R, Braverman ER, et al. (2013) Neurogenetics and Nutrigenomics of Reward Deficiency Syndrome (RDS): Stratification of Addiction Risk and Mesolimbic Nutrigenomic Manipulation of Hypodopaminergic Function. InOmics for Personalized Medicine: 365-398. |
| | | |
|
Badgaiyan RD, Sinha S, Blum K (2015) Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely?. Journal of reward deficiency syndrome 1. |
| | | |
|
|
| | | |
|
McLaughlin T, Blum K, Oscar-Berman M, Febo M, Agan G, et al. (2015) Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: Role of enhanced brain reward functional connectivity and homeostasis redeeming joy. Journal of behavioral addictions 4: 106-115. |
| | | |
|
Blum K, Oscar-Berman M, Jacobs W, McLaughlin T, Gold MS (2014) Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?. Journal of addiction research & therapy 5. |
| | | |
|
|
| | | |
|
|
| | | |
|
|
| | | |
|
Ahmadi J (2016) Alcohol and Drug Use at the US-Mexico Border–Does Cross-Border Mobility make a Difference. J Drug Abuse 2: 1. |
| | | |
|
Ahmadi J. Alcohol Withdrawal Craving Treatment with Low Dose of Buprenorphine: A New Experience. |
| | | |
